Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms
Abstract The Enhanced Permeability and Retention (EPR) effect has been recognized as the
central paradigm in tumor-targeted delivery in the last decades. In the wake of this concept …
central paradigm in tumor-targeted delivery in the last decades. In the wake of this concept …
Nanoparticles modified with cell-penetrating peptides: Conjugation mechanisms, physicochemical properties, and application in cancer diagnosis and therapy
I Gessner, I Neundorf - International journal of molecular sciences, 2020 - mdpi.com
Based on their tunable physicochemical properties and the possibility of producing cell-
specific platforms through surface modification with functional biomolecules, nanoparticles …
specific platforms through surface modification with functional biomolecules, nanoparticles …
Arginine-rich cell-penetrating peptides induce membrane multilamellarity and subsequently enter via formation of a fusion pore
C Allolio, A Magarkar, P Jurkiewicz… - Proceedings of the …, 2018 - National Acad Sciences
Arginine-rich cell-penetrating peptides do not enter cells by directly passing through a lipid
membrane; they instead passively enter vesicles and live cells by inducing membrane …
membrane; they instead passively enter vesicles and live cells by inducing membrane …
Nanoparticle drug delivery system for glioma and its efficacy improvement strategies: a comprehensive review
J Li, J Zhao, T Tan, M Liu, Z Zeng, Y Zeng… - International Journal …, 2020 - Taylor & Francis
Gliomas are the most common tumor of the central nervous system. However, the presence
of the brain barrier blocks the effective delivery of drugs and leads to the treatment failure of …
of the brain barrier blocks the effective delivery of drugs and leads to the treatment failure of …
Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review
Y Zhang, P Guo, Z Ma, P Lu, D Kebebe… - Journal of …, 2021 - Springer
Although nanomedicine have greatly developed and human life span has been extended,
we have witnessed the soared incidence of central nervous system (CNS) diseases …
we have witnessed the soared incidence of central nervous system (CNS) diseases …
The role of cell‐penetrating peptides in potential anti‐cancer therapy
M Zhou, X Zou, K Cheng, S Zhong, Y Su… - Clinical and …, 2022 - Wiley Online Library
Due to the complex physiological structure, microenvironment and multiple physiological
barriers, traditional anti‐cancer drugs are severely restricted from reaching the tumour site …
barriers, traditional anti‐cancer drugs are severely restricted from reaching the tumour site …
Predicting cell-penetrating peptides using machine learning algorithms and navigating in their chemical space
ECL de Oliveira, K Santana, L Josino… - Scientific reports, 2021 - nature.com
Cell-penetrating peptides (CPPs) are naturally able to cross the lipid bilayer membrane that
protects cells. These peptides share common structural and physicochemical properties and …
protects cells. These peptides share common structural and physicochemical properties and …
Cell-penetrating peptides to enhance delivery of oligonucleotide-based therapeutics
G McClorey, S Banerjee - Biomedicines, 2018 - mdpi.com
The promise of nucleic acid based oligonucleotides as effective genetic therapies has been
held back by their low bioavailability and poor cellular uptake to target tissues upon systemic …
held back by their low bioavailability and poor cellular uptake to target tissues upon systemic …
Antimicrobial peptides and cell-penetrating peptides: non-antibiotic membrane-targeting strategies against bacterial infections
X Huang, G Li - Infection and Drug Resistance, 2023 - Taylor & Francis
The prevalence of antimicrobial resistance (AMR) has been rising quickly in recent years.
AMR has emerged as a significant obstacle to the treatment of infectious diseases, and …
AMR has emerged as a significant obstacle to the treatment of infectious diseases, and …
The use of liposomes functionalized with the NFL-TBS. 40–63 peptide as a targeting agent to cross the in vitro blood–brain barrier and target glioblastoma cells
A Mellinger, LJ Lubitz, C Gazaille, G Leneweit… - International Journal of …, 2023 - Elsevier
Glioblastoma is the most common and aggressive brain tumor. Current treatments do not
allow to cure the patients. This is partly due to the blood–brain barrier (BBB), which limits the …
allow to cure the patients. This is partly due to the blood–brain barrier (BBB), which limits the …